About PreciseDx
PreciseDx is a company based in New York (United States) founded in 2019 by Michael Donovan, Jack Zeineh, Gerardo Fernandez, and Carlos Cordon-Cardo.. PreciseDx has raised $31.95 million across 2 funding rounds from investors including Philips, LabCorp and Quest Diagnostics. PreciseDx offers products and services including PreciseBreast and OncoIntelligence. PreciseDx operates in a competitive market with competitors including PathAI, PAIGE, EnSpectra Health, Proscia and Qritive, among others.
- Headquarter New York, United States
- Founders Michael Donovan, Jack Zeineh, Gerardo Fernandez, Carlos Cordon-Cardo
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precisedx, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.95 M (USD)
in 2 rounds
-
Latest Funding Round
$11.23 M (USD), Series B
May 28, 2025
-
Investors
Philips
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreciseDx
PreciseDx offers a comprehensive portfolio of products and services, including PreciseBreast and OncoIntelligence. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for breast cancer risk classification from slides
System for predicting tumor recurrence in breast cancer
Unlock access to complete
Unlock access to complete
Funding Insights of PreciseDx
PreciseDx has successfully raised a total of $31.95M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.23 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $11.2M
-
First Round
First Round
(20 Feb 2024)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - PreciseDx | Valuation | Eventide Asset Management | |
| Feb, 2024 | Amount | Series B - PreciseDx | Valuation | Eventide Asset Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PreciseDx
PreciseDx has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Philips, LabCorp and Quest Diagnostics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Eventide is engaged in values-based investment management services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PreciseDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PreciseDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precisedx Comparisons
Competitors of PreciseDx
PreciseDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, PAIGE, EnSpectra Health, Proscia and Qritive, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-enabled tools for computational pathology and cancer diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Developer of medical devices for tissue imagining and cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
|
|
| domain | founded_year | HQ Location |
AI-based oncology diagnostic solution based on microscopic images & patient data
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precisedx
Frequently Asked Questions about PreciseDx
When was PreciseDx founded?
PreciseDx was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Where is PreciseDx located?
PreciseDx is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of PreciseDx?
Eric T. Converse is the current CEO of PreciseDx.
Is PreciseDx a funded company?
PreciseDx is a funded company, having raised a total of $31.95M across 2 funding rounds to date. The company's 1st funding round was a Series B of $20.72M, raised on Feb 20, 2024.
What does PreciseDx do?
PreciseDx was founded in 2019 in New York, United States, within the healthcare technology sector. An AI-based software platform is developed for analyzing medical images, particularly pathological samples. Diseases are predicted through AI-driven examination of patient images. Image enhancement features are incorporated, alongside workflow management tools. Diagnosis and treatment planning for healthcare professionals are supported across operations in the United States.
Who are the top competitors of PreciseDx?
What products or services does PreciseDx offer?
PreciseDx offers PreciseBreast and OncoIntelligence.
Who are PreciseDx's investors?
PreciseDx has 6 investors. Key investors include Philips, LabCorp, Quest Diagnostics, Eventide, and GenHenn Capital.